Industry Experience

Tim focuses his practice on counseling emerging growth life science companies in connection with a variety of financing, strategic partnership and merger and acquisition transactions. Tim also has extensive experience representing public company business development teams in respect of early-stage strategic investments and purchase options.

experience +

experience –

Prior to joining the firm, Tim was an attorney at Skadden, Arps, Slate, Meagher & Flom LLP. Tim also served as Investment & Operations Counsel at a prominent value-focused hedge fund. He began his legal career with Wilmer Cutler Pickering Hale & Dorr LLP.

Recent Client Work +

Recent Client WOrk –

  • Acquisition of a private European gene therapy company by a Nasdaq-listed biotechnology company
  • Call option exercise and acquisition of a private medical aesthetics technology company by a Spain-based global pharmaceutical company
  • Acquisition of a Nasdaq-listed clinical-stage biopharmaceutical company by a Nasdaq-listed global pharmaceutical company
  • Auction of a Nasdaq-listed advisory services firm
  • Consultation and advice in respect of a development and commercialization collaboration between global pharmaceutical companies
  • Series C financing of an enterprise software company
  • Strategic Series B investment by an NYSE-listed advanced composites company in an early-stage materials science company
  • Convertible Debt investment by an NYSE-listed advanced composites company in an early-stage aerospace company

Community +

Community –

Bar Admissions
  • Massachusetts
Education
  • University of Michigan Law School, Dean's Scholarship
  • Brown University, B.A.